ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Top brokers name 3 ASX shares to buy today
Share Market News
Top ASX fund manager is seeing some of the best buying opportunities in over a decade
Growth Shares
How investing $1,000 into ASX shares can make you rich
Share Market News
Leading brokers name 3 ASX 200 shares to sell today
Share Fallers
Why Inghams, Orora, Redbubble, & ResMed shares are dropping lower
Share Gainers
Broker calls time on this top performing ASX healthcare stock
⏸️ ASX Shares
3 five-star ASX 200 shares to buy in May
Share Market News
Leading brokers name 3 ASX 200 shares to buy today
⏸️ TMF AMP
ASX 200 Weekly Wrap: ASX starts May with a slide
⏸️ TMF AMP
ASX 200 finishes the week down 5%
⏸️ TMF AMP
ASX 200 crashes 3.8%: ASX banks sink lower and ResMed impresses
Share Gainers
Why Fisher & Paykel Healthcare, Helloworld, Janus Henderson, & ResMed are charging higher
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
